We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M Turnover 16.91%
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$160M
AUM Growth
+$15.9M
Cap. Flow
+$6.81M
Cap. Flow %
4.26%
Top 10 Hldgs %
31.05%
Holding
148
New
17
Increased
36
Reduced
37
Closed
18
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.8 years

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$2.78M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$1.4M
3
WU icon
Western Union
WU
+$1.03M
4
DD icon
Du Pont De Nemours E I
DD
+$845K
5
TEX icon
Terex
TEX
+$811K

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.04%
2 Real Estate 13.42%
3 Energy 12.85%
4 Technology 11.92%
5 Healthcare 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GNH
126
DELISTED
GLOBAL ENERGY HOLDINGS GROUP INC COM STK
GNH
$0 ﹤0.01%
82,558
– –
2013 Q2
4 quarters

Similar funds

Benchmark Capital Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Benchmark Capital Advisors held 148 positions worth $160M, up 11% from $144M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Benchmark Capital Advisors deployed $6.81M of net new capital in Q2 2014, opening 17 new positions and adding to 36 existing holdings. Its largest new stake was SELECT INCOME REIT: 239,671 shares worth $3.12M.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, up from 18% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Qualcomm, an estimated $2.78M trimmed.

  • Benchmark Capital Advisors's largest Q2 2014 buy was SELECT INCOME REIT: 239,671 shares worth $3.12M.
  • Benchmark Capital Advisors added most to Yahoo Inc in Q2 2014, an estimated $3.35M increase.
  • Benchmark Capital Advisors's biggest Q2 2014 reduction was Qualcomm, cutting an estimated $2.78M.
  • Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q2 2014, selling an estimated $1.4M.
  • Benchmark Capital Advisors's ten largest holdings make up 31% of its $160M portfolio in Q2 2014.
  • Benchmark Capital Advisors opened 17 new positions and closed 18 in Q2 2014.
  • Benchmark Capital Advisors's portfolio value rose 11% quarter-over-quarter to $160M.

Based on Benchmark Capital Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.